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Abstract
Background: While patterns of incidence of clinical influenza have been well described, much uncertainty remains over
patterns of incidence of infection. The 2009 pandemic provided both the motivation and opportunity to investigate
patterns of mild and asymptomatic infection using serological techniques. However, to date, only broad epidemiological
patterns have been defined, based on largely cross-sectional study designs with convenience sampling frameworks.
Methods and Findings: We conducted a paired serological survey of a cohort of households in Hong Kong, recruited using
random digit dialing, and gathered data on severe confirmed cases from the public hospital system (.90% inpatient days).
Paired sera were obtained from 770 individuals, aged 3 to 103, along with detailed individual-level and household-level risk
factors for infection. Also, we extrapolated beyond the period of our study using time series of severe cases and we
simulated alternate study designs using epidemiological parameters obtained from our data. Rates of infection during the
period of our study decreased substantially with age: for 3–19 years, the attack rate was 39% (31%–49%); 20–39 years, 8.9%
(5.3%–14.7%); 40–59 years, 5.3% (3.5%–8.0%); and 60 years or older, 0.77% (0.18%–4.2%). We estimated parameters for a
parsimonious model of infection in which a linear age term and the presence of a child in the household were used to
predict the log odds of infection. Patterns of symptom reporting suggested that children experienced symptoms more
often than adults. The overall rate of confirmed pandemic (H1N1) 2009 influenza (H1N1pdm) deaths was 7.6 (6.2–9.5) per
100,000 infections. However, there was substantial and progressive increase in deaths per 100,000 infections with increasing
age from 0.66 (0.65–0.86) for 3–19 years up to 220 (50–4,000) for 60 years and older. Extrapolating beyond the period of our
study using rates of severe disease, we estimated that 56% (43%–69%) of 3–19 year olds and 16% (13%–18%) of people
overall were infected by the pandemic strain up to the end of January 2010. Using simulation, we found that, during 2009,
larger cohorts with shorter follow-up times could have rapidly provided similar data to those presented here.
Conclusions: Should H1N1pdm evolve to be more infectious in older adults, average rates of severe disease per infection
could be higher in future waves: measuring such changes in severity requires studies similar to that described here. The
benefit of effective vaccination against H1N1pdm infection is likely to be substantial for older individuals. Revised pandemic
influenza preparedness plans should include prospective serological cohort studies. Many individuals, of all ages, remained
susceptible to H1N1pdm after the main 2009 wave in Hong Kong.
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Influenza A infection causes substantial morbidity and mortality
each year [1]. Periodically, novel human strains emerge, spread
rapidly, and cause increased incidence of infection, as was the case
with the novel 2009 strain of H1N1 pandemic influenza
(H1N1pdm) [2]. However, because many influenza infections
are either asymptomatic or cause only mild symptoms, it is difficult
to measure infection, rather than clinical disease, across a
population [3]. With only clinical data, establishing robust rates
of severe disease per infection is difficult. Also, it is not possible to
establish traditional risk factors for infection. Hence, it is
challenging to generate evidence-based advice for individuals
and policy makers about the value of interventions designed to
reduce the chance of infection, such as vaccination, social
distancing, and other nonpharmaceutical interventions.
Previous community-based serological surveys of populations
outside Hong Kong have established a broad consistent pattern for
the 2009 influenza pandemic, namely, high rates of infection in
school-aged children relative to younger adults and lower rates in
older adults: Australia [4–7]; Belgium [8]; China [9]; Costa Rica
[8]; England and Wales [10]; Germany [8]; India [11]; Japan [8];
New Zealand [12]; Scotland [13]; Singapore [14]; Thailand [15];
and the United States of America [8,16]. Also, our own previous
work has established a similar age-specific pattern of infection
during the first wave in Hong Kong and per-infection mortality
rates that escalated sharply with age, [17]. However, previous
studies rely almost exclusively on noncohort designs and
convenient recruitment, thus leaving a number of important issues
unaddressed. For example, accurately estimating low attack rates
in older individuals is challenging without paired sera, thus
preventing robust estimates of severe disease in older individuals.
Also, the absence of individual-level data other than age and sex
prevents the investigation of straightforward hypotheses about
possible risk factors for infection.
Here, we describe a longitudinal community cohort study of the
main wave of the 2009 (H1N1) influenza pandemic in Hong
Kong, with a design somewhat similar to the seroepidemiological
components of the Tecumseh [18] and Seattle [19] studies. A
substantive difference between our design and these two previous
studies was that we attempted to recruit a representative sample of
all households from a large well-mixed population, rather than
restricting ourselves to a convenient sample of households with
school-aged children.
Methods
Ethics Statement
All study protocols were approved by The Institutional Review
Board of the University of Hong Kong/Hospital Authority Hong
Kong West Cluster.
Baseline Telephone Recruitment
Households were approached to take part in the study on the
basis of their fixed-line telephone number. Numbers were obtained
from two sources, either directly from random calling of residential
landline numbers for Hong Kong (the direct group), or from a
subgroup of participants that had already completed a parallel
study of risk behaviors [20] and had indicated that they would be
willing to be called again (the parallel group; Table S1). Members
of the parallel study had themselves been recruited using random
fixed-line phone numbers by the same team of call centre
operatives.
We attempted to ‘‘bracket’’ the main wave of the pandemic by
obtaining blood samples as soon as possible and then collecting
follow-up samples when the peak of transmission had passed
(Figure 1). The first baseline sample was taken on 4 July 2009 and
the last on 19 September 2009. We started to follow-up individuals
when clinical surveillance suggested that a substantial peak in
transmission had passed. The first follow-up sample was taken on
11 November 2009 and the last taken on 6 February 2010. We
invited participants to follow-up appointments in the order that
they had attended for the baseline visit. However, if participants
were unavailable for the initial appointment, we offered them as
many further opportunities as required for them to attend (within
the period of the study). The detailed pattern of recruitment
timing, by individual, is presented in Figure S1.
When the phone was answered, we attempted to speak to an
individual from the household who was at least 18 y old and who
normally slept in the household for at least 5 nights per week. We
explained the objectives of the study and asked the respondent if
they and members their household were interested in participat-
ing. If the respondent agreed, we asked them to estimate the
number of members of the household who would participate and
we made an appointment for the household to visit the study
clinic. The respondent was informed that at least one member of
the household would be required to give a blood sample in order
for the household to be eligible to enter the study.
Time (2009-2010)
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Figure 1. Timing of study recruitment relative to the time
series of hospitalized cases in Hong Kong, by week of onset.
Colors are coded for age groups in both charts: red, 3–19 y; green, 20–
39 y; blue, 40–59 y; and magenta 60 y and older. (A) Shows the timing
of recruitment of members of the study. (B) Shows the time series of
hospitalized cases in Hong Kong, by week of onset.
doi:10.1371/journal.pmed.1000442.g001
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On arrival at the study clinic, each individual was given an
information sheet and the opportunity to question a member of
the study team. Informed consent was obtained individually for
either full participation in the study, or for participation without
giving a blood sample. For children aged 8–17, we obtained
written consent from both the child and their parent or guardian.
For children aged 2–7, written consent was obtained from the
parent or guardian. A questionnaire was administered and ,8m l
whole blood was obtained. Participating households were given a
tympanic thermometer. Households were allowed to keep the
thermometer at the end of the study. Participants who gave a
blood sample were compensated with 100 HKD (<US$13).
Incentives were given as either supermarket vouchers (adults) or
book tokens (children).
Reporting of Symptoms
Participants were asked to report when any member of the
household was experiencing two or more of: fever (.37.5uC,
temperature measured only when a fever was suspected), cough,
sputum, sore throat, runny nose, or myalgia. Participants were
offered three methods of reporting. First, we asked them to phone
the study team directly to report symptoms as soon as possible.
Second, we asked them to fill out a paper diary with the day and
type of the symptoms. Third, during a follow-up interview, we
asked them if they had experienced any symptoms between
baseline and follow-up and, if so, what symptoms they had
experienced. For each mode of reporting, we constructed three
types of symptomatic episode: acute respiratory infection (ARI, all
reported episodes of symptoms), influenza-like illness (ILI, fever
plus cough or sore throat), and fever alone.
Laboratory Techniques
Blood samples were refrigerated at 4uC in the clinic and
transferred (,1 h) using a cool box to the study laboratory later
that evening. The next morning, samples were centrifuged at
1,500 rpm for 10 min and the sera extracted. The sera were
frozen to 230uC for storage. For testing, sera were thawed and
then heat inactivated at 56uC for 30 min. Replicate serum
dilutions were mixed with 100 tissue culture infectious dose 50
(TCID50) of A/California/4/2009 (H1N1pdm) for 2 h and then
transferred onto preformed monolayers of Madin-Darby Canine
Kidney (MDCK) cells grown in 96-well microtitre plates. The
plates were incubated at 37uCi n5 %C O 2 for 3 d. Neutralization
of virus cytopathogenic effect (CPE) was observed under an
inverted microscope to determine the highest serum dilution that
neutralized $50% of the wells. A virus back titration, positive
controls, and negative controls were included in each assay. The
sensitivity of the test method was benchmarked using a standard
positive control serum 09/194 provided by the National Institute
for Biological Standards and Control, Centre for Health
Protection, London. Neutralization tests, rather than hemagglu-
tination tests, were chosen for assaying antibody responses to
pandemic influenza H1N1 virus because neutralization tests are
more sensitive for patients with virologically confirmed pandemic
H1N1 infection [21].
Individuals were classified as seroconverters if there was a 4-fold
or greater rise in their neutralization titre between baseline and
follow-up. Initially, all samples were screened at dilutions of 1:20
and 1:40 with baseline and follow-up serum samples tested in
parallel in the same set of assays. If exposure status or
seroconversion status from the screening dilutions was unambig-
uous after these screening assays, no further titrations were
performed. For all other pairs of sera, antibody titration was
performed in 2-fold dilutions from 1:10 to 1:1,280.
Data on Severe Cases
From the start of May 2009, patients admitted to public
hospitals in Hong Kong with acute respiratory illness were
routinely tested for H1N1pdm using reverse transcription (RT)-
PCR. Every case for which a test was conducted was entered into
an information management system administered by the Hospital
Authority (eFlu). This system was integrated with the Hong-Kong–
wide network for electronic notes and assigned a unique identifier
based on Hong Kong identification numbers. In Hong Kong, 90%
of inpatient bed days are in the public system [22]. We cross-
referenced every positive test result with admissions and discharge
data for the entire public system to identify individuals who had
tested positive and subsequently been admitted to intensive care
units (ICU) or who had died while in hospital. We removed
duplicate hospital episode records, keeping the record closest to,
but after, the positive test.
Inferring Rates of Severe Disease
Estimating the number of infections per severe case would be
straightforward if recruitment and follow-up had occurred during
short periods of time and antibody titres rose immediately after
infection. However, because of the rolling nature of recruitment
and follow-up and the delay in the rise of antibody titres after
infection, we developed a simple likelihood-based framework to
estimate the number of infections per severe case for each age
group, where a severe case could be an individual admitted to
hospital, one admitted to an ICU, or a fatal case. Inference for a
specific combination of age group and level of severity was
independent of other combinations. Effectively, the proportion of
an age group infected was equal to the number of severe cases,
divided by the probability that an infection resulted in a severe
case, expressed as a proportion of the total number of people in
that age group (with adjustment for rising titres). Confidence
intervals based on this approach reflect uncertainty arising from
the size of the study and do not reflect other sources of uncertainty
such as the variability in the speed with which antibody titres rise
and the overall percentage of individuals whose antibodies rise
after infection (we assumed 100%). Therefore, our results may
slightly underestimate the number of infections. Details are given
in Text S1.
Simulation Study
In order to investigate alternate study designs and to validate
our estimates of the rate of severe disease per infection, we
developed a simulation of exactly the stochastic process assumed
by the likelihood calculation above. For any given study protocol,
we summed the number of actual severe cases between baseline
and follow-up (for each individual, adjusting for rising titres) and
then chose randomly between individuals being infected or not
infected on the basis of the probability of severe infection. Thus,
we could use the same likelihood framework to analyse results
from the simulation studies as was used for the actual data.
Results
Study Population
Paired sera were obtained from 770 individuals living in 469
study households. Our response rates were (for households): 1.8%
of all residential landlines selected (n=26,205) and 3.7% of all
households in which an eligible adult completed the initial call
(n=12,834) (Figure S2; Table S1). We compared the overall
H1N1 Pandemic Cohort Study
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sera were obtained (Table S2). It is reassuring that our study
population was representative of children aged 3–19 and adults of
60 y and older. The distribution of adults in the study between the
ages of 20 and 59 was skewed towards older individuals, compared
with the Hong Kong population in general. Women were more
likely to take part in the study than were men, as were those with a
bachelor’s degree education or higher.
Age and the Risk of Infection
The infection attack rate declined with increasing age. For those
aged: 3–19, the attack rate was 39% (95% confidence interval
31%–49%); 20–39 y, 8.9% (5.3%–14.7%); 40–59 y, 5.3% (3.5%–
8.0%); and 60 y or older, 0.77% (0.18%–4.2%). The attack rate in
the oldest group had wide confidence intervals because only a
single infection was observed in 131 participants. Differences in
rates of seroconversion could not be explained by baseline titres,
which were similar across age groups (Figure S3; Table S3). For
example, five of 112 individuals ages 3–19 y had baseline titres of
1:40 compared with eight of 131 individuals aged 60 y or older.
In order to fully capture the influence of age on the risk of
infection, we used the Akaike Information Criterion (AIC) to
compare three alternative regression models: 20-y age classes,
AIC=414.1; linear age, AIC=413.0; and a restricted cubic spline
model, AIC=407.7. We considered spline fits with between 3 and
8 knots: the 5-knot curve was best able to explain the data. The
fitted spline function corresponded well with age-based rolling
average of infection incidence and shows: a sharp drop in risk of
infection ages older than school age, followed by a plateau for
middle ages, before another sharp drop for older adults
(Figure 2A).
The presence of a child in the household explained the plateau
in the age-risk of infection in these data. We adjusted the spline
model using a binary variable for the presence or absence of a
child in the household and compared the shape of the odds ratio
curve (Figure 2B, blue line, AIC=406.1) with the unadjusted
model: the odds ratio curve was more linear, with less pronounced
turning points. Therefore, we also fitted the linear age model,
adjusted for the presence or absence of a child. We found that the
adjusted linear model was a more parsimonious explanation for
the data (Figure 2B, green line; Table 1, model A, AIC=405.5,
DAIC=0). The age-adjusted odds ratio for infection for those in a
household without children was 0.39 (0.21–0.73), relative to those
living in households with children.
Other Risk Factors
We had substantive interest in six other potential risk factors, in
addition to age and the presence or absence of a child in the
household. In order to efficiently prioritize model selection, we
calculated the AIC for all possible regression models (63 nonempty
subsets of six risk factors) combined with linear age and the
presence or absence of a child in the household. None of the 63
models had a lower AIC than model A. Only three additional risk
factors appeared in models not substantially different from model
A on the AIC scale (DAIC ,3): district of residence, sex, and status
for 2008/2009 influenza vaccination (Table 1). Even though
univariate analyses suggested association in some cases, the
following three risk factors did not appear in models close to the
best model: household size (best DAIC=7.4), profession (best
DAIC=6.4), and level of education (best DAIC=5.4).
Residents of New Territories East had an increased risk of
infection during the study period, even after adjusting for other
risk factors of interest (Table 1, model B, DAIC=2.5), with an
odds ratio of 2.6 (1.1–6.2) relative to residents of Hong Kong
Island. Although sex was included in a number of well-fitting
models, the odds ratio for males relative to females was close to
unity in the adjusted model, suggesting that correlation between
sex and other risk factors in the study group was somewhat
different from that in the wider population. Although not
statistically significant, estimates of the adjusted odds ratio for
vaccine status suggest that those who reported being vaccinated in
2008/2009 were at an increased risk of infection.
In order to control for possible bias from the two alternate
sources of recruitment (the direct group or the parallel group), we
included the source of recruitment as a possible confounder in a
final mutually adjusted regression model, model C. This model
scored slightly worse on the AIC scale than did model B
(DAIC=3.5), with only very minor changes in estimated odds
ratios and confidence intervals. Although recruitment from the
parallel group was associated with an increased risk of infection,
the estimated odds ratio was not significantly different from unity.
We also considered a baseline titre of 1:40 or greater as a risk
factor for infection (despite this variable being a component of the
outcome variable, Table S3). Even though a low baseline titre was
protective, the small number of raised titres observed ensured that
this variable had little explanatory power (DAIC for model A with
baseline titre added as a binary variable =1.1).
Individual-level data from the serological survey are provided as
Dataset S1 with the fields defined in Table S4.
Symptoms
Rates of reported symptoms were low, but varied substantially
by definition and by mode of reporting (Figure 3). In general,
when reporting by phone or by symptom diary, between 10% and
20% of seroconverters reported having experienced symptoms.
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Figure 2. Age and risk of infection. (A) Shows the average
probability of infection for median age (x-axis) in rolling windows of 100
study participants (black circles), the best-fit probability of infection (red
line, univariate restricted cubic spline), and 95% confidence intervals
(grey area). (B) Shows the log-odds, relative to age 1, for: the same best-
fit univariate spline fit as in (A) (red); the spline age model adjusted for
the presence of a child in the household (blue); and a linear model
adjusted for the presence of a child (green, best-fitting model A in
Table 1).
doi:10.1371/journal.pmed.1000442.g002
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considerably higher. Rates of reporting by follow-up interview
were considerably higher. Febrile symptoms for seroconverting
children were reported by phone more often than for adults who
seroconverted (Table 2). Of the 41 children seroconverters in the
study, ten reported by phone that they had experienced a fever
and, of those, seven reported ILI. In contrast only one of 40 adult
seroconverters in the study had telephoned us to report a febrile
illness (and also ILI).
Rates of Severe Disease
The overall rate of confirmed H1N1pdm-associated deaths was
7.6 (6.2–9.5) per 100,000 infections. Rates of severe disease
increased with age (Figure 4A). Although rates of hospitalization
per infection were not substantially different for the younger three
age groups (,1%), individuals aged 60 and older were at slightly
increased risk. However, rates of mortality increased substantially
with age. The risk of death per infection for 3–19 y olds was 1.3
(1.0–1.7) per 100,000 while the risk for individuals aged 60 or
older was 220 (50–4,000) per 100,000. Wide confidence intervals
for 60 y and older were driven by the single observed infection in
that group. However, the general trend of rapidly increasing
mortality with age can be seen clearly across the other adult age
groups.
Cumulative Attack Rate up to End January 2010
Although we aimed to obtain bracketing sera (Figure 1), there
was substantial transmission outside of the period of our study.
Therefore, we used the total number of confirmed severe cases to
estimate the age-specific cumulative infection attack rates for a
longer period of time than was captured by our study (Figure 4B).
Table 1. Risk factors for infection with 2009 H1N1 pandemic influenza for 667 participants of the study for whom paired sera were
tested and for whom complete information was available.
Risk Factor DAIC
a Value Univariate Models Model A Model B Model C
OR 95% CI OR 95% CI OR 95% CI OR 95% CI
Age 7.5 1 y old 1.0 — 1.0 — 1.0 — 1.0 —
Per year older than 1 0.93 0.92–0.95 0.94 0.93–0.96 0.94 0.93–0.96 0.94 0.93–0.96
Child in house 59.6 Present 1.0 — 1.0 — 1.0 — 1.0 —
Not present 0.18 0.098–0.32 0.39 0.21–0.75 0.4 0.21–0.75 0.4 0.21–0.75
Sex 101.9 Female 1.0 — — — 1.0 — 1.0 —
Male 1.3 0.79–2.0 — — 0.95 0.56–1.6 0.94 0.55–1.6
District 96.4 HK Island 1.0 — — — 1.0 — 1.0 —
KLN East 1.2 0.42–3.2 — — 1.2 0.39–3.5 1.2 0.40–3.6
KLN West 1.9 0.73–4.9 — — 2.7 0.96–7.8 2.8 0.98–7.9
NT East 3.1 1.4–6.9 — — 2.6 1.1–6.2 2.5 1.1–6.1
NT West 1.9 0.81–4.7 — — 1.5 0.56–3.8 1.4 0.55–3.7
Vaccination 2008/
2009
102.5 Not vaccinated 1.0 — — — 1.0 — 1.0 —
Vaccinated 1.2 0.66–2.1 — — 1.5 0.79–3.0 1.4 0.55–3.7
Recruitment 99.8 Direct 1.0 — — — — — 1.0 —
Parallel 1.5 0.95–2.4 — — — — 1.3 0.77–2.2
DAIC
b 0 2.5 3.5
Data for one individual missing vaccination status and for another two were missing education status.
aAIC for individual univariate models relative to that of the best fit multivariate model A.
bAIC for mutually adjusted multivariate models, relative to that of Model A.
CI, confidence interval; HK, Hong Kong; KLN, Kowloon; NT, New Territories (outlying islands included in NT West); OR, odds ratio.
doi:10.1371/journal.pmed.1000442.t001
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Figure 3. Absolute levels of symptom reporting. Three different
definitions of symptoms were used: ILI, acute respiratory infection, or
fever (see main text for details). Symptoms were reported by one of:
study participants phoning into the study phone line, by symptom
diary, or at follow-up interview. We also report an all-inclusive rate: the
percentage of seroconverters that reported symptoms by any of the
three modes. 95% confidence bounds are based on the binomial
distribution.
doi:10.1371/journal.pmed.1000442.g003
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there were 7,981 hospitalizations, 109 admissions to ICU, and 70
deaths among laboratory confirmed cases of H1N1pdm. Using the
rates of severe disease per infection, these totals suggest cumulative
infection attack rates of: 14% (11%–17%), based on hospitaliza-
tion; 16% (13%–19%), based on ICU admission; and 14% (12%–
18%), based on deaths.
Simulation of a Nonbracketing Design
We simulated an alternate trial design in which 500 samples
were obtained from each of the four age groups during the week
containing 1 June 2009 and the 500 follow-up samples were
obtained from each age group during the week containing 30
September 2009 (Figure 4C). In this trial design, fewer infections
and many fewer severe cases were observed. However, despite the
reduced power of the alternate design, overall rates of severity are
well estimated and the pattern of increasing severity with age is
readily apparent. Even though no infections were observed in
some of the simulated studies in the 60 and older age class, it was
still possible to establish a relatively high lower bound for rates of
severe disease. Although we present results for ICU as an example,
the results for admission to hospital and death are not substantively
different.
Discussion
The main wave of the 2009 (H1N1) pandemic infected many
more children than it did adults. These differences are not
explained by baseline antibody titres to H1N1pdm, but could be
explained partly by social mixing patterns of the population in
these different age strata. However, given that social mixing
patterns within the 20–60-y age range do not exhibit substantial
variation [23], and that we have controlled for the presence of a
child in the household, it is plausible that increasing age leads to
decreased susceptibility independently of mixing and titres to
H1N1pdm, possibly as a result of repeated seasonal influenza
infections, but by a mechanism not detectable by assays for
neutralizing antibody. Whether this reflects antibody that protects
by mechanisms other than neutralization, such as antibody-
dependent cell cytotoxicity or cell-mediated immunity, remains
worthy of investigation.
While older adults had low infection rates, those individuals
infected developed severe disease much more frequently. Further,
our results suggest that individuals over 60 y experience very high
absolute rates of severe outcomes, with approximately one
reported and positively tested death for every 200 infections. If
continuing waves of H1N1pdm infection are driven by antigenic
drift, and if that drift decreases the efficiency of the cross-
protection currently possessed by older adults, it is likely that
future waves could have higher overall mortality than initial
waves. Surveillance of clusters of severe disease in older adults
should be prioritized because this may be the first clear signal of a
significant antigenic evolutionary event. The efficacy of alternate
vaccine formulations in preventing infection in older individuals
should be assessed as a matter of priority [24].
The low rate of ILI reported by phone and symptom diary for
seroconverters in this study is consistent with results from an
independent parallel study of household contacts of children in
Hong Kong [21]. However, much higher rates of symptoms were
reported in military personal in Singapore [25]. These differences
may be driven by the age distributions of the different cohorts. The
Singapore cohort was much younger: our comparison of symptom
Table 2. Symptoms reported by study participants by infection status, symptom definition, and method of reporting.
Reporting Method Seroconverted Nonseroconverted
Age Groups p-Value Age Groups p-Value
n 0–18 y (%) n 19+ y( % ) n 0–18 y (%) n 19+ y( % )
n Laboratory tested (%) 41 (48%) 45 (52%) 57 (8%) 627 (92%)
ILI
a
Phone 7 (17%) 1 (2%) 0.059
b 2 (4%) 12 (2%) 0.335
b
Diary 9 (22%) 3 (7%) 0.122
b 3 (5%) 10 (2%) 0.093
b
Follow-up interview 19 (46%) 11 (24%) 0.206
c 7 (12%) 44 (7%) 0.289
c
Any of the above source 24 (59%) 11 (24%) 0.059
c 11 (19%) 57 (9%) 0.054
c
Acute respiratory infection
d
Phone 9 (22%) 2 (4%) 0.052
b 4 (7%) 27 (4%) 0.327
b
Diary 18 (44%) 11 (24%) 0.260
c 9 (16%) 80 (13%) 0.716
c
Follow-up interview 24 (59%) 26 (58%) 0.888
c 26 (46%) 192 (31%) 0.143
c
Any of the above source 31 (76%) 26 (58%) 0.539
c 29 (51%) 204 (33%) 0.084
c
Fever
e
Phone 10 (24%) 1 (2%) 0.009
b 2 (4%) 14 (2%) 0.637
b
Diary 9 (22%) 5 (11%) 0.387
c 5 (9%) 20 (3%) 0.059
b
Follow-up interview 21 (51%) 13 (29%) 0.234
c 8 (14%) 53 (9%) 0.302
c
Any of the above source 27 (66%) 14 (31%) 0.084
c 13 (23%) 67 (11%) 0.034
c
aILI is defined as fever (temperature of 37.5uC or above) + cough or sore throat.
bFisher’s exact test.
cChi-squared test.
dDefined as any two of fever
e, cough, phlegm, sore throat, running nose, and myalgia.
eTemperature of 37.5uC or above.
doi:10.1371/journal.pmed.1000442.t002
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observed in adults was likely due to a reduced rate of experiencing
symptoms, rather than just to a reduced propensity to report. The
proportion of uninfected children that reported febrile illness was
similar to that of uninfected adults. However, our results do
suggest that adults are slightly less likely to report symptoms during
a follow-up interview than are children. In general, rates of
reporting were much higher but less specific when participants
were asked a direct question during the follow-up interview
compared with more passive symptom diaries or participant call-
in. Future studies attempting to address rates of illness associated
with influenza infection should attempt more intensive prospective
follow-up of participants to minimize potential recall bias.
Our study has a number of limitations. Firstly, we did not
measure incidence in children aged 2 and lower, who are much
more likely to be admitted to hospital for acute respiratory
infection than other age groups, but less likely to be infected with
pandemic influenza than older children [26]. Given our focus on
the use of paired sera, this shortcoming was unavoidable. The
incorporation of data from cross-sectional samples from young
children is the topic of ongoing investigation. Also, our cases are
defined by an observed 4-fold rise in titre, which may not have
occurred for all infections; and we will not have captured all severe
cases as some H1N1pdm cases will have entered the private
hospital system (although this is likely to have occurred much more
rarely than the average rate of ,10% for all types of admission).
We suggest that the combined effect of imperfect test sensitivity
and imperfect severe case matching will have generated only
minor biases in our estimates of infection rates and severe disease
rates and that the two effects will have acted in opposite directions.
Figure 4. (A) Overall and age-specific estimated rates of severe disease per infection; squares for hospitalization, triangles for
admission to ICUs, and circles for death. (B) Estimated cumulative attack rates for infection up to the end of January 2010. Three separate
estimates of cumulative infection attack rate are given for each age group, on the basis of the three levels of severity, with symbols as per (A). (C)
Comparison of estimates of rates of ICU admission per infection from the current study (black triangles, as per (A)) with estimates of the same statistic
from ten simulations of an alternate, nonbracketing, study design (see text).
doi:10.1371/journal.pmed.1000442.g004
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period of the pandemic in Hong Kong, we made the assumption
that the testing process for individuals who became hospitalized
was consistent. This is almost certainly not the case for all
hospitalized individuals. In particular, anecdotal evidence suggests
that less severe hospitalized cases were less likely to be tested for
H1N1pdm after the end of September. Analysis of the rate of
admission to ICU per positive hospital admission supports the
anecdotal evidence (unpublished data). Therefore, it is reassuring
that estimates of the overall and age-specific attack rates based on
the three different outcome measures (hospitalization, admission to
ICU, and death) are largely consistent.
We cannot exclude the possibility of substantial sampling bias in
our serological survey. We were only able to successfully obtain
paired sera from an average of 1.6 individuals in ,2% of
households initially identified by random telephone number
selection. Although similar in many respects, after using common
demographic characteristics to compare the study population with
the wider Hong Kong population (age, sex, district, and
education), we cannot exclude the possibility that individuals
more likely to take part in our study had a different probability of
infection than the population at large. However, we suggest that
the potential impact of sampling bias in our results (and the value
of evidence presented here in general) should be assessed on a
result-by-result basis against the background of other reported
community surveys of the 2009 influenza pandemic.
For the 2009 Hong Kong pandemic season, the current results
add substantially to our earlier work [17] in a number of ways.
Using an entirely different sampling scheme, the current study
confirms the general pattern of sharply decreasing age-specific
rates of infection for a similar period of the epidemic, for the age
ranges contained in both studies: thus strengthening the case for
rapid cross-sectional serological studies on the basis of convenient
samples [17] at the same time as suggesting that serious sampling
biases were not present in either study. Also, to a certain extent,
multiple recruitment groups in the current study provided a proxy
for propensity to take part: those recruited via the parallel study
had already agreed to complete one telephone questionnaire and
to be contacted again for other studies. Having agreed for a third
time to take part, by enrolling in the main serological survey, it
seems reasonable to assume that parallel study recruits are from a
subset of the population more likely to take part in this type of
study. Although our univariate estimate of the odds ratio for the
parallel recruitment group was greater than one, compared with
the direct group, the inclusion of recruitment source as a covariate
did not improve the parsimony of our multivariate regression
model. Also, the strength of the odds ratio for the parallel group in
the univariate model was reduced substantially when adjusting for
our epidemiological variables of interest. Therefore, although it is
certainly possible that propensity to take part in the paired
serological study was correlated with the risk of infection,
comparison with our previously published cross-sectional study
and comparison of our two recruitment groups suggests that
sample bias was of considerably lesser influence on infection than
variables we were able to measure directly, such as age and the
presence of a child in the household.
The current study, by recruiting from a wide age range using
the same sampling framework and a paired sera outcome, allows
us to add to the available literature in a number of other ways. We
present important data on infection rates and severity for those
aged 60 y and older that were not reported in our previous study
[17]: even the single observed 4-fold rise in titre out of 131 paired
samples is valuable. In an age group typically at high risk from
influenza morbidity and mortality, these data allow an informative
upper bound for the absolute risk of infection and, hence, an
informative lower bound for the absolute risk of severe outcomes.
Without paired samples, obtaining accurate bounds for estimates
of low rates of incidence from cross-sectional samples is
problematic. When trying to estimate low rates of incidence with
cross-sectional data, statistical noise becomes significant in the
numerator: to overcome this noise, large sample sizes are required.
Good evidence for high absolute risk in a particular age group may
be of substantial public health value for the prioritization of
interventions.
With good data on other potential risk factors for infection, we
were able to show how the presence of a child in the household
could explain an apparent age plateau in risk of infection, while
variables such as education and profession did not appear to be
risk factors once adjusted for age. This type of traditional risk-
factor analysis is not possible with unlinked samples for which only
the following variables are usually available: age, sex, and clinic
location. Similarly, our analysis of home district (using only a
single clinic location) suggests that micro-scale spatial heterogene-
ities persisted for longer than might have been expected in a large
well-connected population. For the period of our study, residents
of one district (New Territories East) appeared to be at
substantially greater risk of infection than were residents of other
districts. It is possible that the overall level of transmission was
higher in that one district than in other districts, or that the
epidemic occurred sooner there than it did elsewhere. Further, it
seems possible that, in Hong Kong, spatial decorrelation took a
long time to occur or never did occur. Individual-based models of
respiratory infections, parameterized with the commuting patterns
of adults [27], and also those parameterized with explicit school
locations [28,29], suggest much more rapid spread at small scales
in large populations. Had the pandemic strain been more severe,
good knowledge of small-scale spatiotemporal patterns could have
been of value in optimizing the provision of key health care
facilities and the timing of rolling school closures.
Our results can be compared with serology-based studies of
influenza incidence in other populations during the 2009 (H1N1)
pandemic [4–16]. In England and Wales, a study of cross-sectional
clinical samples found substantial increases in the proportion of
younger children with titres 1:32 or greater between a 2008
baseline (n=1,403) and sample taken in September 2009
(n=1,954), thus giving valuable early evidence that the infection
attack rate was high in some age groups and, hence, that the rate
of severe cases per infection in the most affected age groups was
likely to be low [10]. As already mentioned above, the consistency
of our results for Hong Kong between the current study and our
previous cross-sectional study [17] validates the use of convenient
clinical samples during the early stages of a pandemic as a useful
tool for the estimation of incidence in high-incidence groups.
However, a high degree of cross-reactivity in hemagglutination
inhibition assays in sera from adults in many studies introduced
considerable statistical noise and prevented reliable estimates of
attack rates in older age groups. In Singapore, sera were collected
from four groups: an existing sample of healthy adults (n=838),
military personnel (n=1,213), staff from an acute care hospital
(n=558), and staff and residents of a long-term care facility
(n=300) [14]. Although an overall infection attack rate of 13%
was observed in this study, it is difficult to generalize these results
because no subgroup contained school-aged children and many of
the infection events occurred in the military substudy.
It is more difficult to compare our community-wide results with
historical studies such as the Tecumseh [18] and Seattle [19]
study. Both were designed to efficiently obtain viral samples from
households with children and, therefore, did not attempt to recruit
H1N1 Pandemic Cohort Study
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sampling framework for households with children is difficult to
obtain. However, future analyses of household-level data from the
current study and follow-up waves should permit a like-for-like
comparison between the subgroups in the Hong Kong study and
canonical historical studies of respiratory infection.
Our simulation results show that a larger paired-sera cohort
study with a shorter follow-up period could have generated—more
rapidly—similar data to those presented here. We suggest that this
revised design would be a valuable addition to revised pandemic
preparedness plans for a small subset of large well-connected
global cities. Sentinel hospitals could be established in early-
affected populations to help ensure that the testing process remains
consistent for ICU cases throughout the epidemic curve. Given
that (a) many believe the 2009 response to have been overzealous
and (b) the severity of the next pandemic strain is not known, there
appears to be a substantial risk that the public health impact of the
next pandemic will be underestimated. Therefore, revised
preparedness plans should prioritize reactive studies that can
rapidly and reliably distinguish between 2009 (H1N1)-like strains
(,1:10,000 infection fatality rate) and more severe pandemics. If
the next pandemic strain were similar in all other respects, but had
an infection fatality rate of ,1:1,000; we could reasonably expect
peak demand on key health care services such as ICU to be ten
times greater than that observed during 2009/2010 [30].
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Background. From June 2009 to August 2010, the world
was officially (according to specific WHO criteria—WHO
phase 6 pandemic alert) in the grip of an Influenza A
pandemic with a new strain of the H1N1 virus. During this
time, more than 214 countries and overseas territories
reported laboratory confirmed cases of pandemic influenza
H1N1 2009 with almost 20,000 deaths.
While much is already known about patterns of incidence of
clinical influenza, the patterns of infection incidence are
much more uncertain, because many influenza infections are
either asymptomatic or cause only mild symptoms. This
means that it is difficult to obtain accurate estimates of risk
factors for infection and the overall burden of disease using
only clinical surveillance. However, without accurate esti-
mates of infection incidence across different risk groups, it is
not possible to establish the number of infections that give
rise to severe disease (the per infection rate of severe
disease). Consequently, it is difficult to give evidence-based
advice for individuals, groups, and populations about the
potential benefits of interventions including drugs and
vaccines that might reduce the risk of influenza infection.
Why Was This Study Done? During the 2009 pandemic,
some countries and territories, such as Hong Kong, were able
to investigate patterns of mild and asymptomatic infection
using serological techniques, thus providing information that
may help to fill this knowledge gap. Given the high levels of
polymerase chain reaction (PCR) testing and the robust
reporting of hospital episodes, the main H1N1 pandemic
wave in Hong Kong (during September 2009) provided an
opportunity to implement a prospective cohort study to
investigate the incidence of infection.
What Did the Researchers Do and Find? The researchers
collected data on the asymptomatic symptoms of influenza
by randomly selecting households to participate in the
study. Each member of the household willing to participate
had a baseline blood sample taken before the main wave of
the pandemic (July to September 2009), then, when clinical
surveillance suggested that the main peak in transmission
had passed, after the main wave (November 2009 to
February 2010). During the study period, participants were
asked to report any flu-like symptoms in three ways: to
phone the study team and report symptoms in real time; to
fill out a paper diary with the day and symptoms; and to
report symptoms during a follow-up interview. In parallel,
the researchers monitored data on every patient with H1N1
admitted to intensive care units or who died while in the
hospital. The researchers then estimated the number of
H1N1 infections (infection incidence) per severe case by
developing a likelihood-based framework. They used a
simulation model to investigate alternate study designs
and to validate their estimates of the rate of severe disease
per infection.
Using these methods, the researchers found that rates of
H1N1 infection during the study period decreased substan-
tially with age: for 3–19 years, the attack rate was 39%; 20–39
years, 8.9%; 40–59 years, 5.3%; and 60 years or older, 0.77%.
In addition, patterns of symptom reporting indicated that
children experienced symptoms more often than adults. The
overall rate of confirmed H1N1 deaths was 7.6 per 100,000
infections. However, there was a substantial and progressive
increase in deaths per 100,000 infections with increasing age
from 0.66 for 3–19 years up to 220 for 60 years and older.
Statistical modeling suggested that 56% of 3–19 year olds
and 16% of people overall were infected by the pandemic
strain up to the end of January 2010.
What Do These Findings Mean? The results of this study
suggest that more children were infected with H1N1 than
adults but most of them did not progress to severe disease.
Conversely, although fewer older adults were infected with
H1N1, this group was much more likely to experience severe
disease. Therefore, should H1N1 infection incidence ever
increase in older adults, for example by evolving to become
more infectious to this group, average rates of severe disease
per infection could be much higher than for the 2009
pandemic. Revised pandemic preparedness plans should
include prospective serological cohort studies, such as this
one, in order to be able to estimate rates of severe disease
per infection.
Additional Information. Please access these Web sites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1000442.
N WHO has information about the global response to the
2009 H1N1 pandemic
N WHO also provides recommendations for the H1N1 post-
pandemic period
N The government of Hong Kong’s Centre for Health
Protection provides information about H1N1 in Hong Kong
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